Evaxion A/S (EVAX) stock
EVAXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$2.77+0.03 (+1.09%)
Close on Nov 16, 2026Market cap $23.10MP/E –Yield –
Evaxion A/S profit margin
Profit margin (net margin) is net income as a percentage of revenue.
For fiscal 2025 it was -102.4%, against -316.0% the year before.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -102.4% | +213.6 |
| FY2024 | Dec 31, 2024 | -316.0% | +29992.2 |
| FY2023 | Dec 31, 2023 | -30308.2% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2025 | Jun 30, 2025 | -13056.8% | – |
| Q2 FY2024 | Jun 30, 2024 | -4024.7% | – |
See a number that looks wrong?